Spatiotemporal Analyses of 2 Co-Circulating SARS-CoV-2 Variants, New York State, USA
- PMID: 35133957
- PMCID: PMC8888210
- DOI: 10.3201/eid2803.211972
Spatiotemporal Analyses of 2 Co-Circulating SARS-CoV-2 Variants, New York State, USA
Abstract
The emergence of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants in late 2020 and early 2021 raised alarm worldwide because of their potential for increased transmissibility and immune evasion. Elucidating the evolutionary and epidemiologic dynamics among novel SARS-CoV-2 variants is essential for understanding the trajectory of the coronavirus disease pandemic. We describe the interplay between B.1.1.7 (Alpha) and B.1.526 (Iota) variants in New York State, USA, during December 2020-April 2021 through phylogeographic analyses, space-time scan statistics, and cartographic visualization. Our results indicate that B.1.526 probably evolved in New York City, where it was displaced as the dominant lineage by B.1.1.7 months after its initial appearance. In contrast, B.1.1.7 became dominant earlier in regions with fewer B.1.526 infections. These results suggest that B.1.526 might have delayed the initial spread of B.1.1.7 in New York City. Our combined spatiotemporal methodologies can help disentangle the complexities of shifting SARS-CoV-2 variant landscapes.
Keywords: COVID-19; New York; SARS-CoV-2; United States; coronavirus disease; respiratory infections; severe acute respiratory syndrome coronavirus 2; spatiotemporal analyses; vaccine-preventable diseases; viruses; zoonoses.
Figures




Similar articles
-
Emerging Variants of SARS-CoV-2 and Novel Therapeutics Against Coronavirus (COVID-19).2023 May 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 May 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 34033342 Free Books & Documents.
-
Detecting COVID-19 Clusters at High Spatiotemporal Resolution, New York City, New York, USA, June-July 2020.Emerg Infect Dis. 2021 May;27(5):1500-4. doi: 10.3201/eid2705.203583. Emerg Infect Dis. 2021. PMID: 33900181 Free PMC article.
-
Clinical and Genomic Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Infections in mRNA Vaccinated Health Care Personnel in New York City.Clin Infect Dis. 2022 Aug 24;75(1):e774-e782. doi: 10.1093/cid/ciab886. Clin Infect Dis. 2022. PMID: 34644393 Free PMC article.
-
The Evolution and Biology of SARS-CoV-2 Variants.Cold Spring Harb Perspect Med. 2022 May 27;12(5):a041390. doi: 10.1101/cshperspect.a041390. Cold Spring Harb Perspect Med. 2022. PMID: 35444005 Free PMC article. Review.
-
SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.Int Rev Immunol. 2023;42(6):393-414. doi: 10.1080/08830185.2022.2079642. Epub 2022 May 28. Int Rev Immunol. 2023. PMID: 35635216 Review.
Cited by
-
Variant-specific introduction and dispersal dynamics of SARS-CoV-2 in New York City - from Alpha to Omicron.PLoS Pathog. 2023 Apr 18;19(4):e1011348. doi: 10.1371/journal.ppat.1011348. eCollection 2023 Apr. PLoS Pathog. 2023. PMID: 37071654 Free PMC article.
-
Genomic surveillance of SARS-CoV-2 in Puerto Rico enabled early detection and tracking of variants.Commun Med (Lond). 2022 Aug 11;2:100. doi: 10.1038/s43856-022-00168-7. eCollection 2022. Commun Med (Lond). 2022. PMID: 35968047 Free PMC article.
-
ViralVar: A Web Tool for Multilevel Visualization of SARS-CoV-2 Genomes.Viruses. 2022 Dec 5;14(12):2714. doi: 10.3390/v14122714. Viruses. 2022. PMID: 36560718 Free PMC article.
-
Emergence of SARS-CoV-2 Delta Variant and Effect of Nonpharmaceutical Interventions, British Columbia, Canada.Emerg Infect Dis. 2023 Oct;29(10):1999-2007. doi: 10.3201/eid2910.230055. Epub 2023 Aug 28. Emerg Infect Dis. 2023. PMID: 37640374 Free PMC article.
-
The role of socio-economic disparities in the relative success and persistence of SARS-CoV-2 variants in New York City in early 2021.PLoS Pathog. 2024 Jun 20;20(6):e1012288. doi: 10.1371/journal.ppat.1012288. eCollection 2024 Jun. PLoS Pathog. 2024. PMID: 38900824 Free PMC article.
References
-
- Frampton D, Rampling T, Cross A, Bailey H, Heaney J, Byott M, et al. Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study. Lancet Infect Dis. 2021;21:1246–56. 10.1016/S1473-3099(21)00170-5 - DOI - PMC - PubMed
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous